The global metered dose inhalers market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of respiratory diseases and growing awareness about the benefits of MDIs. The MDI segment accounted for the largest share in the global metered dose inhalers market in 2018, followed by nebulizers and dry powdered inhalers.
The chronic obstructive pulmonary devices segment accounted for the largest share in the global metered dose inhalers market in 2018, followed by asthma respiratory devices and other applications. North America was estimated to account for a major share of this market owing to high prevalence rates of respiratory diseases such as asthma and COPD among adults and children residing there.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of asthma and COPD, coupled with the growing awareness about the benefits of Metered Dose Inhalers are some factors that are driving the growth of this market.
- Increasing number of respiratory diseases in developing countries such as China and India is also expected to drive the growth of this market.
- Increasing government initiatives for improving healthcare infrastructure in developing countries such as China and India is also expected to drive the growth of this market.
- Lack of awareness about Metered Dose Inhalers among patients.
Industry Growth Insights published a new data on “Metered Dose Inhalers Market”. The research report is titled “Metered Dose Inhalers Market research by Types (Dry Powdered Inhaler, Pressurized Metered Dose Inhalers, Nebulizers, Connected Metered Dose Inhalers), By Applications (Chronic Obstructive Pulmonary Devices, Asthma, Other Respiratory Devices), By Players/Companies Presspart Manufacturing Ltd, Beximco Pharma Ltd, 3M Pharmaceuticals Pty Ltd, Anomatic Innovation & Design Center & Manufacturing, Intech Biopharm Corporation, Cipla Inc, Midascare Pharmaceuticals Pvt, GlaxoSmithKline Pharmaceuticals Ltd, Biocare Manufacturing Sdn Bhd, Aristo Pharma Ltd, Swiss Pharmaceuticals Pvt”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Metered Dose Inhalers Market Research Report
By Type
Dry Powdered Inhaler, Pressurized Metered Dose Inhalers, Nebulizers, Connected Metered Dose Inhalers
By Application
Chronic Obstructive Pulmonary Devices, Asthma, Other Respiratory Devices
By Companies
Presspart Manufacturing Ltd, Beximco Pharma Ltd, 3M Pharmaceuticals Pty Ltd, Anomatic Innovation & Design Center & Manufacturing, Intech Biopharm Corporation, Cipla Inc, Midascare Pharmaceuticals Pvt, GlaxoSmithKline Pharmaceuticals Ltd, Biocare Manufacturing Sdn Bhd, Aristo Pharma Ltd, Swiss Pharmaceuticals Pvt
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Metered Dose Inhalers Market Report Segments:
The global Metered Dose Inhalers market is segmented on the basis of:
Types
Dry Powdered Inhaler, Pressurized Metered Dose Inhalers, Nebulizers, Connected Metered Dose Inhalers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Chronic Obstructive Pulmonary Devices, Asthma, Other Respiratory Devices
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Presspart Manufacturing Ltd
- Beximco Pharma Ltd
- 3M Pharmaceuticals Pty Ltd
- Anomatic Innovation & Design Center & Manufacturing
- Intech Biopharm Corporation
- Cipla Inc
- Midascare Pharmaceuticals Pvt
- GlaxoSmithKline Pharmaceuticals Ltd
- Biocare Manufacturing Sdn Bhd
- Aristo Pharma Ltd
- Swiss Pharmaceuticals Pvt
Highlights of The Metered Dose Inhalers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dry Powdered Inhaler
- Pressurized Metered Dose Inhalers
- Nebulizers
- Connected Metered Dose Inhalers
- By Application:
- Chronic Obstructive Pulmonary Devices
- Asthma
- Other Respiratory Devices
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Metered Dose Inhalers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Metered dose inhalers (MDIs) are a type of asthma medication that delivers a fixed amount of medicine through the mouth using an aerosol. MDIs can be used to treat both mild and severe asthma.
Some of the major players in the metered dose inhalers market are Presspart Manufacturing Ltd, Beximco Pharma Ltd, 3M Pharmaceuticals Pty Ltd, Anomatic Innovation & Design Center & Manufacturing, Intech Biopharm Corporation, Cipla Inc, Midascare Pharmaceuticals Pvt, GlaxoSmithKline Pharmaceuticals Ltd, Biocare Manufacturing Sdn Bhd, Aristo Pharma Ltd, Swiss Pharmaceuticals Pvt.
The metered dose inhalers market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Metered Dose Inhalers Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Metered Dose Inhalers Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Metered Dose Inhalers Market - Supply Chain
4.5. Global Metered Dose Inhalers Market Forecast
4.5.1. Metered Dose Inhalers Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Metered Dose Inhalers Market Size (000 Units) and Y-o-Y Growth
4.5.3. Metered Dose Inhalers Market Absolute $ Opportunity
5. Global Metered Dose Inhalers Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Metered Dose Inhalers Market Size and Volume Forecast by Type
5.3.1. Dry Powdered Inhaler
5.3.2. Pressurized Metered Dose Inhalers
5.3.3. Nebulizers
5.3.4. Connected Metered Dose Inhalers
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Metered Dose Inhalers Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Metered Dose Inhalers Market Size and Volume Forecast by Application
6.3.1. Chronic Obstructive Pulmonary Devices
6.3.2. Asthma
6.3.3. Other Respiratory Devices
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Metered Dose Inhalers Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Metered Dose Inhalers Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Metered Dose Inhalers Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Metered Dose Inhalers Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Metered Dose Inhalers Demand Share Forecast, 2019-2026
9. North America Metered Dose Inhalers Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Metered Dose Inhalers Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Metered Dose Inhalers Market Size and Volume Forecast by Application
9.4.1. Chronic Obstructive Pulmonary Devices
9.4.2. Asthma
9.4.3. Other Respiratory Devices
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Metered Dose Inhalers Market Size and Volume Forecast by Type
9.7.1. Dry Powdered Inhaler
9.7.2. Pressurized Metered Dose Inhalers
9.7.3. Nebulizers
9.7.4. Connected Metered Dose Inhalers
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Metered Dose Inhalers Demand Share Forecast, 2019-2026
10. Latin America Metered Dose Inhalers Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Metered Dose Inhalers Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Metered Dose Inhalers Market Size and Volume Forecast by Application
10.4.1. Chronic Obstructive Pulmonary Devices
10.4.2. Asthma
10.4.3. Other Respiratory Devices
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Metered Dose Inhalers Market Size and Volume Forecast by Type
10.7.1. Dry Powdered Inhaler
10.7.2. Pressurized Metered Dose Inhalers
10.7.3. Nebulizers
10.7.4. Connected Metered Dose Inhalers
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Metered Dose Inhalers Demand Share Forecast, 2019-2026
11. Europe Metered Dose Inhalers Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Metered Dose Inhalers Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Metered Dose Inhalers Market Size and Volume Forecast by Application
11.4.1. Chronic Obstructive Pulmonary Devices
11.4.2. Asthma
11.4.3. Other Respiratory Devices
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Metered Dose Inhalers Market Size and Volume Forecast by Type
11.7.1. Dry Powdered Inhaler
11.7.2. Pressurized Metered Dose Inhalers
11.7.3. Nebulizers
11.7.4. Connected Metered Dose Inhalers
11.8. Basis Point Share (BPS) Analysis by Type 11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Metered Dose Inhalers Demand Share, 2019-2026
12. Asia Pacific Metered Dose Inhalers Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Metered Dose Inhalers Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Metered Dose Inhalers Market Size and Volume Forecast by Application
12.4.1. Chronic Obstructive Pulmonary Devices
12.4.2. Asthma
12.4.3. Other Respiratory Devices
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Metered Dose Inhalers Market Size and Volume Forecast by Type
12.7.1. Dry Powdered Inhaler
12.7.2. Pressurized Metered Dose Inhalers
12.7.3. Nebulizers
12.7.4. Connected Metered Dose Inhalers
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Metered Dose Inhalers Demand Share, 2019-2026
13. Middle East & Africa Metered Dose Inhalers Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Metered Dose Inhalers Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Metered Dose Inhalers Market Size and Volume Forecast by Application
13.4.1. Chronic Obstructive Pulmonary Devices
13.4.2. Asthma
13.4.3. Other Respiratory Devices
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Metered Dose Inhalers Market Size and Volume Forecast by Type
13.7.1. Dry Powdered Inhaler
13.7.2. Pressurized Metered Dose Inhalers
13.7.3. Nebulizers
13.7.4. Connected Metered Dose Inhalers
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Metered Dose Inhalers Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Metered Dose Inhalers Market: Market Share Analysis
14.2. Metered Dose Inhalers Distributors and Customers
14.3. Metered Dose Inhalers Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Presspart Manufacturing Ltd
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Beximco Pharma Ltd
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. 3M Pharmaceuticals Pty Ltd
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Anomatic Innovation & Design Center & Manufacturing
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Intech Biopharm Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Cipla Inc
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Midascare Pharmaceuticals Pvt
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. GlaxoSmithKline Pharmaceuticals Ltd
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Biocare Manufacturing Sdn Bhd
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Aristo Pharma Ltd
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Swiss Pharmaceuticals Pvt
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
